Biotech · Public company · Emeryville, CA, US
Kyverna Therapeutics, Inc.
Ticker KYTX · SEC CIK 0001994702
Track this companyFree. Adds Kyverna Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials96 recruiting or active
Pipeline programs11From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline11
- KYV-101Phase 3 · Myasthenia GravisClinicalTrials.gov · fetched Nov 12, 2026
- Standard lymphodepletion regimenPhase 3 · Myasthenia GravisClinicalTrials.gov · fetched Nov 12, 2026
- Anti-CD20 mABPhase 2 · Multiple Sclerosis, Primary ProgressiveClinicalTrials.gov · fetched Nov 12, 2026
- KYV-101Phase 2 · Systemic SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- KYV-101Phase 2 · Multiple Sclerosis, Primary ProgressiveClinicalTrials.gov · fetched Nov 12, 2026
- KYV-101 anti-CD19 CAR-T cell therapyPhase 2 · Lupus NephritisClinicalTrials.gov · fetched Nov 12, 2026
- Standard lymphodepletion regimenPhase 2 · Lupus NephritisClinicalTrials.gov · fetched Nov 12, 2026
- Standard lymphodepletion regimenPhase 2 · Multiple Sclerosis, Primary ProgressiveClinicalTrials.gov · fetched Nov 12, 2026
- Standard lymphodepletion regimenPhase 2 · Stiff-Person SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- Standard lymphodepletion regimenPhase 2 · Systemic SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- KYV-101Refractory Lupus NephritisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials9
- A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101RECRUITING · started Nov 24, 2025ClinicalTrials.gov NCT07403188 · fetched Nov 12, 2026
- KYSA-8: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Treatment Refractory Stiff Person SyndromePHASE2 · COMPLETED · started Sep 25, 2024ClinicalTrials.gov NCT06588491 · fetched Nov 12, 2026
- KYSA-7: A Study of Anti-CD19 CAR T-Cell Therapy, in Subjects With Refractory Primary and Secondary Progressive Multiple SclerosisPHASE2 · ACTIVE_NOT_RECRUITING · started Sep 20, 2024ClinicalTrials.gov NCT06384976 · fetched Nov 12, 2026
- KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia GravisPHASE2_PHASE3 · RECRUITING · started Aug 28, 2024ClinicalTrials.gov NCT06193889 · fetched Nov 12, 2026
- KYSA-5: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Systemic SclerosisPHASE1_PHASE2 · TERMINATED · started Aug 6, 2024ClinicalTrials.gov NCT06400303 · fetched Nov 12, 2026
- CARTIMMUNE: Study of Patients With Autoimmune Diseases Receiving KYV-101PHASE1 · ACTIVE_NOT_RECRUITING · started Aug 5, 2024ClinicalTrials.gov NCT06152172 · fetched Nov 12, 2026
- A Study of KYV-101, a CD19 CAR T Cell Therapy, in Participants With Treatment Refractory Progressive Multiple SclerosisPHASE1 · ACTIVE_NOT_RECRUITING · started Jun 20, 2024ClinicalTrials.gov NCT06451159 · fetched Nov 12, 2026
- A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple SclerosisPHASE1 · RECRUITING · started Apr 10, 2024ClinicalTrials.gov NCT06138132 · fetched Nov 12, 2026
- KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus NephritisPHASE1_PHASE2 · TERMINATED · started Apr 28, 2023ClinicalTrials.gov NCT05938725 · fetched Nov 12, 2026
SEC filings12
- 8-K · 8-KSEC EDGAR · filed Sep 24, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 11, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 11, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 27, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 9, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 2, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 18, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 12, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 12, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 4, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Apr 22, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Apr 22, 2026 · fetched Nov 12, 2026